USPTO serial 79003728
Serial No. 79003728
Reviewed by CopyMark Law Group
Status 402
- Filing date
- Status date
- Registration date
- —
- Examiner
- KING, LINDA M
- Law office
- TMO LAW OFFICE 116 - EXAMINING ATTORNEY ASSIGNED
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with Serial No. 79003728?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medicines for human purposes (Antibiotics, Acne medications, Acne treatment preparations, Adjuvants for use with vaccines, Allergy medications, Anesthetics for non-surgical use, Anesthetics for surgical use, Anesthetics for surgical and non-surgical use, Anthelmintics, Antipyretic analgesics, Anti-itch cream, Anti-itch ointment, Bacterial and bacteriological preparations for medical or veterinary purposes, Blood substitute for human, Diuretics, Medicated bath preparations, Medicated lotions for skin, Medicated skin care preparations, Biochemical preparations for medical or veterinary purposes, Pharmaceutical products and preparations for hydrating the skin during pregnancy, Topical anesthetics, Articles for headache); pharmaceutical preparations (Bacterial and bacteriological preparations for medical or veterinary purposes, Pharmaceutical antitussive-cold preparations, Pharmaceutical anti-allergic preparations and substances, Pharmaceutical for the treatment of erectile dysfunction, Pharmaceutical preparations for use in chemotherapy, Pharmaceutical preparation for the treatment of gout, Pharmaceutical preparations for the treatment of heart rhythm disorders, Pharmaceutical preparations for the treatment of infectious diseases Pharmaceutical preparations acting on the central nervous system, Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases, Pharmaceutical preparations for animal skincare, Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension, Pharmaceutical preparations for ocular or intraocular surgery, Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis, Pharmaceutical preparations for treating allergic rhinitis and asthma, Pharmaceutical preparations for treating diabetes, Pharmaceutical preparations for treating skin disorders, Pharmaceutical preparations for use in dermatology, Pharmaceutical preparations for wounds, Pharmaceutical products and preparations against dry skin caused by pregnancy, Pharmaceutical products and preparations for chloasma, Pharmaceutical products and preparations for hydrating the skin during pregnancy, Pharmaceutical products and preparations for pregnancy blemishes, Pharmaceutical products and preparations for preventing skin blemishes during pregnancy, Pharmaceutical products and preparations to prevent stretch marks, Pharmaceutical products and preparations to prevent swelling in the legs, Pharmaceutical products for ophthalmological use, Pharmaceutical products for skin care for animals, Pharmaceutical products for the treatment of bone diseases, Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer, Pharmaceutical products for treating respiratory diseases and asthma, Pharmaceutical skin lotions Pharmaceutical solutions used in dialysis, Pharmaceuticals for the treatment of erectile dysfunction, Antibacterial pharmaceuticals, Anti-diabetic pharmaceuticals, Astringents [pharmaceutical], Cardiovascular pharmaceuticals, Dermatological pharmaceutical products); chemical-pharmaceutical preparations (Anesthetics for non-surgical use, Anesthetics for surgical and non-surgical use, Biological preparations for medical purposes, Biological and chemical preparations and reagents for medical or veterinary use, Ferments for medical or veterinary use, Topical anesthetics, Sterilising preparations, Pharmaceutical preparations for use in chemotherapy, Veterinary vaccines) | SECTION 70 - CANCELLED | — |
| 016 | Stickers, paper labels | SECTION 70 - CANCELLED | — |
| 035 | Conducting marketing studies; promoting the sales of goods and services of others through the distribution of printing material and promoting contests; dissemination of advertising mater | SECTION 70 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 23, 2013 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Mar 7, 2008 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Jul 6, 2006 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 9, 2006 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 9, 2006 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 2, 2005 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Nov 1, 2005 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Mar 29, 2005 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 28, 2005 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 2, 2005 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 25, 2005 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 25, 2005 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 14, 2004 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 14, 2004 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 8, 2004 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 3, 2004 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 11, 2004 | NWAP | NEW APPLICATION ENTERED | — |
| Aug 9, 2004 | SDRC | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | — |